Childress Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Sell |
16,613
-2,459
| -13% | -$59.6K | 0.1% | 147 |
|
|
2025
Q1 | $483K | Buy |
19,072
+5,378
| +39% | +$136K | 0.14% | 107 |
|
|
2024
Q4 | $363K | Sell |
13,694
-31,257
| -70% | -$829K | 0.1% | 136 |
|
|
2024
Q3 | $1.3M | Sell |
44,951
-982
| -2% | -$28.4K | 0.35% | 50 |
|
|
2024
Q2 | $1.29M | Buy |
45,933
+29,017
| +172% | +$812K | 0.36% | 46 |
|
|
2024
Q1 | $469K | Sell |
16,916
-3,318
| -16% | -$92.1K | 0.14% | 99 |
|
|
2023
Q4 | $583K | Buy |
20,234
+436
| +2% | +$12.6K | 0.17% | 80 |
|
|
2023
Q3 | $643K | Buy |
19,798
+14,286
| +259% | +$464K | 0.21% | 71 |
|
|
2023
Q2 | $202K | Sell |
5,512
-986
| -15% | -$36.2K | 0.09% | 72 |
|
|
2023
Q1 | $265K | Sell |
6,498
-14,138
| -69% | -$577K | 0.12% | 71 |
|
|
2022
Q4 | $1.06M | Buy |
20,636
+2,073
| +11% | +$106K | 0.35% | 51 |
|
|
2022
Q3 | $825K | Sell |
18,563
-669
| -3% | -$29.7K | 0.32% | 60 |
|
|
2022
Q2 | $1.01M | Buy |
19,232
+1,768
| +10% | +$92.7K | 0.4% | 50 |
|
|
2022
Q1 | $903K | Buy |
17,464
+2,542
| +17% | +$131K | 0.32% | 59 |
|
|
2021
Q4 | $881K | Sell |
14,922
-2,394
| -14% | -$141K | 0.36% | 52 |
|
|
2021
Q3 | $744K | Buy |
17,316
+4,019
| +30% | +$173K | 0.3% | 64 |
|
|
2021
Q2 | $520K | Buy |
13,297
+41
| +0.3% | +$1.6K | 0.24% | 69 |
|
|
2021
Q1 | $480K | Buy |
13,256
+5,719
| +76% | +$207K | 0.22% | 89 |
|
|
2020
Q4 | $277K | Buy |
+7,537
| New | +$277K | 0.16% | 76 |
|